Skip to Main Content
Everyone (Public)

Endocrinology Grand Rounds: Dr. Ana Luisa Perdigoto presents Mechanisms of checkpoint inhibitor-induced diabetes: clinical and preclinical insights

Mechanisms of checkpoint inhibitor-induced diabetes: clinical and preclinical insights

Dr. Ana Luisa Perdigoto works in the laboratory of her mentor, Dr. Kevan Herold, and is interested in investigating pancreatic β cell function and responses to inflammation to better understand mechanisms of autoimmune diabetes. Her clinical and research interests have led her to study mechanisms of checkpoint inhibitor-induced diabetes, a complication which occurs in some cancer patients treated with immunotherapies. She hopes to identify novel biomarkers and therapeutic targets for the prevention and/or treatment of these complications as well as potentially spontaneous autoimmune diabetes.

Her lab has identified evidence of pancreatic inflammation in patients with checkpoint inhibitor-induced diabetes. Using a mouse model of checkpoint inhibitor-induced diabetes they identified inflammatory mediators as well as changes in immune and β cells that may lead to the development of diabetes. They show that inhibition of inflammatory cytokines can prevent checkpoint inhibitor-induced diabetes, suggesting a strategy for clinical application to prevent this complication. They hope to expand their work to understand mechanisms of other endocrine complications of checkpoint inhibition.

Speaker

Contact

Admission

Free

Tag

Grand Rounds

Next upcoming occurrences of this event

May 202220Friday
1:00 PM2:00 PM